Occudo Quantitative Strategies’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,593
Closed -$778K 707
2025
Q1
$778K Buy
+20,593
New +$874K 0.1% 276
2024
Q1
Sell
-18,272
Closed -$1.02M 816
2023
Q4
$1.02M Buy
+18,272
New +$911K 0.14% 202
2023
Q3
Sell
-10,332
Closed -$662K 1062
2023
Q2
$662K Buy
+10,332
New +$588K 0.07% 450
2022
Q4
Sell
-25,939
Closed -$1.2M 1080
2022
Q3
$1.2M Buy
+25,939
New +$1.41M 0.09% 337
2022
Q2
Sell
-40,185
Closed -$2.75M 1201
2022
Q1
$2.75M Buy
+40,185
New +$2.86M 0.23% 95

Other funds holding ENOV

Occudo Quantitative Strategies's ENOV Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Enovis (ENOV) in Q2 2025, closing a stake of 20,593 shares — an estimated $778K sold.

Occudo Quantitative Strategies first reported a position in ENOV in Q1 2022 and held it in 5 quarters. The position peaked at $2.75M in Q1 2022. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 20,593 Enovis shares in Q2 2025, an estimated $778K.
  • Occudo Quantitative Strategies first reported a position in Enovis in Q1 2022 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Enovis position peaked at $2.75M in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.